...
首页> 外文期刊>Advances in Experimental Medicine and Biology >Respiratory and systemic infections in children with severe aplastic anemia on immunosuppressive therapy
【24h】

Respiratory and systemic infections in children with severe aplastic anemia on immunosuppressive therapy

机译:免疫抑制治疗严重再生障碍性贫血儿童的呼吸道和全身感染

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the present study we investigated the occurrence of systemic and respiratory infections in a cohort of 123 children with severe acquired aplastic anemia (SAA) on immunosuppressive therapy (IST). We recorded 101 episodes of infection in 77 patients (62.6 %). Pneumonia was among the most frequently observed clinical forms of infection (17 cases-16.8 %). In the entire group, 23 children died, mostly in the course of fatal sepsis (15/23) and in 3 cases because of pneumonia complications. All patients were treated with horse (h-ATG) or rabbit antithymocyte globulin (r-ATG) supplemented with cyclosporine and corticosteroids. The crude incidence rate for serious infections in h-ATG group and r-ATG group was comparable. The relative risk of infectious complications was lower in patients treated with granulocyte colony stimulating factors (G-CSF) by 36 % (RR 0.64; p < 0.0001). The analysis confirmed that respiratory tract and disseminated infections comprise a very serious clinical problem and are the leading cause of death of SAA children. Active surveillance and the analysis of associated risk factors are required to detect opportunistic infections in this group of patients.
机译:在本研究中,我们调查了免疫抑制治疗(IST)导致的123例重度获得性再生障碍性贫血(SAA)儿童的系统性和呼吸道感染的发生。我们记录了77位患者(62.6%)的101次感染事件。肺炎是最常见的临床感染形式之一(17例-16.8%)。在整个组中,有23名儿童死亡,其中多数是在致命性败血症过程中死亡(15/23),还有3例是由于肺炎并发症而死亡。所有患者均接受补充环孢霉素和皮质类固醇的马(h-ATG)或兔抗胸腺细胞球蛋白(r-ATG)治疗。在h-ATG组和r-ATG组中,严重感染的粗略发生率是可比的。接受粒细胞集落刺激因子(G-CSF)治疗的患者感染并发症的相对风险降低了36%(RR 0.64; p <0.0001)。分析证实,呼吸道和传播感染是一个非常严重的临床问题,是SAA儿童死亡的主要原因。需要主动监视和相关危险因素分析,以检测此组患者中的机会性感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号